MCRB Seres Therapeutics, Inc.
Healthcare$7.59-4.17%ClosedMarket Cap: $73.5M
As of 2026-05-26
Valuation
P/E (TTM)
14.89
PEG
0.00
P/B
2.86
P/S
66.87
EV/EBITDA
-2.72
DCF Value
$-3.35
FCF Yield
-55.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
-20.9%
Operating Margin
-7641.0%
Net Margin
-4088.8%
ROE
-127.3%
ROA
-39.9%
ROIC
-80.3%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $358.0K | -118.2% | $-20.9M | $-19.9M | $— | — |
| Q4 null | $438.0K | 3251.8% | $-19.4M | $-15.3M | $— | — |
| FY null | $789.0K | -423.8% | $-94.0M | $5.7M | $— | — |
| Q3 null | $351.0K | -3704.0% | $-22.5M | $8.2M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-24.9M | $-19.9M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-27.2M | $32.7M | $— | — |
| Q4 null | $0.00 | NaN% | $-28.8M | $-15.6M | $— | — |
| FY null | $0.00 | -Infinity% | $-121.3M | $-146.6M | $— | — |
| Q3 null | $0.00 | -Infinity% | $-29.2M | $88.8M | $— | — |
| Q2 null | $0.00 | NaN% | $-28.9M | $-32.9M | $— | — |
| Q1 null | $0.00 | NaN% | $-34.4M | $-40.1M | $— | — |
| Q4 2023 | $64.0K | 100.0% | $-39.5M | $-41.2M | $-6.38 | — |